$LIMN
Liminatus Pharma, Inc. Class A Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$3.40
▲+0.29%+$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLiminatus Pharma, Inc. Class A Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is LIMN up today? It is at $3.40 (+0.29%). See the catalyst behind the move, real-time alerts the moment LIMN spikes, and full due diligence on LIMN — key stats, earnings, dilution and insider activity. Free.
Be first to know when $LIMN makes an unusual move. Create a free account to track $LIMN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LIMN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LIMN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystListing deficiency / delisting riskReverse split up to 1-for-50Status pending stockholder approval, from the latest SEC filing. Read it →Across every filing on file, supply equal to 141.9% of the tradeable float is in play - 141.9% has already been sold.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
1,505,973 new shares (adjusted for the later reverse split)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on LIMN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LIMN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LIMN last traded at $3.40, up 0.29% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Liminatus Pharma, Inc. Class A Common Stock (LIMN) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LIMN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LIMN 0 times in the last 30 days.
LIMN (Liminatus Pharma, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $5M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LIMN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LIMN discussion
Sign in to ask a question or join the discussion.